Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1999
03/17/1999CN1210889A Method for preparing monomer insulin
03/17/1999CN1210866A Preparation of recombinant factor VIII in protein free medium
03/16/1999US5883239 aroA
03/16/1999US5883230 Multidomain hematopoiesis stimulators
03/16/1999US5883227 Multiple sclerosis associated polypeptide
03/16/1999US5883226 Nucleotide sequences of genes
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5882914 Nucleic acids encoding the hypoxia inducible factor-1
03/16/1999US5882910 Lipid kinase
03/16/1999US5882902 Amino acid conjugate
03/16/1999US5882900 Culturing planobispora rosea or mutant under submerged conditions in nutrient medium supplemented with vitamin b12 or analog thereof
03/16/1999US5882898 Cells and vectors with polynucleotides
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882888 DNA integration by transposition
03/16/1999US5882887 Proteins for genetic engineering
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882873 Human DNA sequence encoding a kidney ATP-dependent potassium channel
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882858 Cloning and uses of the genetic locus BCL-6
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5882520 Use of arabinogalactan in aqueous two phase extractions
03/16/1999CA2244232A1 Novel def
03/16/1999CA2236363A1 Novel compound
03/16/1999CA2019463C Antibiotics plusbacin
03/16/1999CA2008825C Reg protein
03/16/1999CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
03/16/1999CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
03/11/1999WO1999011809A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011795A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
03/11/1999WO1999011792A1 Single-stranded antibody against hepatitis b virus core protein, gene thereof, and therapeutic agent for hepatitis b containing these
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011779A1 Dna sequences enhancing promoter activity
03/11/1999WO1999011777A1 Methods for protein screening
03/11/1999WO1999011773A1 Transgenic mammals which produce oligosaccharides in their milk
03/11/1999WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011589A1 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1998057990A3 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
03/11/1999WO1998057986A3 Human preprotachykinin b
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998050547A3 Human toll-like receptor proteins, related reagents and methods
03/11/1999DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
03/11/1999CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999CA2302777A1 Transgenic mammals which produce oligosaccharides in their milk
03/11/1999CA2301157A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2270911A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900841A1 LAG-3 splice variants
03/10/1999EP0900521A1 Insecticidal proteins
03/10/1999EP0900384A2 Novel treatment
03/10/1999EP0900275A1 Methods and reagents for modulating apoptosis
03/10/1999EP0900274A1 MUTANT $i(AEQUOREA VICTORIA) FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE
03/10/1999EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof
03/10/1999EP0900025A1 $i(MORAXELLA CATARRHALIS) OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
03/10/1999EP0795027A4 Method for in vitro protein synthesis
03/10/1999EP0708922B1 Identification of ligands by selective amplification of cells transfected with receptors
03/10/1999EP0644899B1 Production of recombinant human lactoferrin
03/10/1999EP0548214B1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS
03/10/1999CN1210558A Recombinant phages
03/10/1999CN1210150A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
03/10/1999CN1210145A Engineering bacteria for epidermal growth factor and preparation of epidermal growth factor by using this bacteria
03/10/1999CA2243670A1 Novel histidine kinase
03/09/1999US5880333 Transforming plants with vectors which encode receptor polypeptides of class ii steroid and thyroid superfamily, applying chemical which binds to receptor polypeptides and activates target vector gene expression
03/09/1999US5880327 Production of clinically useful quantities of proteins.
03/09/1999US5880274 Feline monoclonal antibody which is expected to be useful for diagnosis, treatment and prevention of feline diseases, especially feline infectious diseases.
03/09/1999US5880273 Platelet activating factor acetylhydrolase, and gene thereof
03/09/1999US5880268 Modulators of the interaction between ICAM-R and αd /CD18
03/09/1999US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists
03/09/1999US5880265 Isolating factor viii and recombinants by anion exchange chromotography resulting in highly pure von willebrand factor having structural integrity, stability and no proteolytic degradation
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880256 Inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of factor viia, factor xia, plasma kallikrein, or plasmin is indicated.
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999US5880094 Polypeptides that stimulate bone growth
03/09/1999US5879942 Processing enzyme for polypeptide
03/09/1999US5879933 Mammalian Retrotransposons
03/09/1999US5879925 Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains
03/09/1999US5879924 Immortalized cell lines for virus growth
03/09/1999US5879912 Method of synthesizing saccharide compositions
03/09/1999US5879911 Cell surface protein expressed on human cortical thymocyte and their use
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879905 In vivo method of initiating protein synthesis with an amino acid other than methionine
03/09/1999US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
03/09/1999US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia.
03/09/1999US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal
03/09/1999US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
03/09/1999US5879673 Administration of thrombopoietin on a single day only
03/09/1999US5879672 Tie-2 ligand 1
1 ... 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 ... 1125